论文部分内容阅读
目的:探讨血清IL-6、BNP水平及RDW与慢性心力衰竭治疗效果及预后的相关性。方法:收集来我院就诊的慢性心力衰竭患者210例,随机分为试验组和对照组,观察两组患者治疗后疗效及预后结果,探讨血清IL-6、BNP水平及RDW与之相关性。结果:试验组和对照组治疗后有效患者和良好预后结局患者血清IL-6、BNP水平和RDW均低于治疗后不良预后结局患者,分别经t检验,差异均有统计学意义(P<0.05)。结论:血清IL-6、BNP水平及RDW与慢性心力衰竭治疗效果及预后存在负相关,可用于慢性心力衰竭治疗效果的评估。
Objective: To investigate the correlation between serum IL-6 and BNP levels and the therapeutic effect and prognosis of RDW and chronic heart failure. Methods: A total of 210 chronic heart failure patients were collected from our hospital and randomly divided into experimental group and control group. The therapeutic effect and prognosis of the two groups were observed. The levels of serum IL-6, BNP and RDW were also investigated. Results: The levels of IL-6, BNP and RDW in patients with effective and good outcome after treatment in trial group and control group were lower than those in patients with poor prognosis after treatment, respectively, with significant difference (P <0.05 ). Conclusion: The levels of serum IL-6, BNP and RDW are negatively correlated with the therapeutic effect and prognosis of chronic heart failure, which can be used to evaluate the therapeutic effect of chronic heart failure.